» Articles » PMID: 29766021

Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model

Overview
Publisher Cell Press
Date 2018 May 17
PMID 29766021
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Adeno-associated virus (AAV) vector is a promising platform technology for ocular gene therapy. Recently clinical successes to treat choroidal neovascularization (CNV) in wet type age-related macular degeneration have been reported. However, because pathologic conditions of the retina may alter the tropism of viral vectors, it is necessary to evaluate the transduction efficiency of different serotypes of AAV vectors in the retinas with CNVs. Here, we show the patterns and efficacy of transduction of AAV2, -5, and -8 vectors in a laser-induced CNV mouse model. C57BL/6J mice were subjected to unilateral laser photocoagulation on the right eye to induce CNV 5 days prior to intravitreal injection of AAV2, -5, and -8 capsids expressing EGFP. Transduction was increased around CNV lesions for all AAV capsid types, and AAV2 resulted in the highest transduction efficiency. In the absence of CNV, the AAV2 vector transduced ganglion and inner nuclear layer (INL) cells, and AAV5 and AAV8 transduced only a small proportion of cells in the retinal ganglion cell layer. CNV increased AAV2 vector expression throughout the retina and in and around CNVs; the transduced cells included retinal ganglion cells, Müller cells, cells from the INL and outer nuclear layer (ONL), photoreceptors, and retinal pigment epithelium (RPE) cells. Inflammatory cells and endothelial cells in CNVs were also transduced by AAV2. AAV5 and AAV8 were transduced in retinal ganglion, Müller, INL, ONL, and RPE cells in a localized pattern, and only endothelial cells at the surface of CNV lesions showed EGFP expression. Taken together, CNV formation resulted in enhanced transduction of AAV2, -5, and -8, and AAV2 exhibited the highest transduction efficiency in cells in CNV lesions.

Citing Articles

Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration.

McNamee S, Akula M, Love Z, Nasraty N, Nystuen K, Singh P Sci Rep. 2024; 14(1):16490.

PMID: 39019967 PMC: 11254931. DOI: 10.1038/s41598-024-67095-6.


AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies.

Castro B, Steel J, Layton C BioDrugs. 2023; 38(1):73-93.

PMID: 37878215 PMC: 10789843. DOI: 10.1007/s40259-023-00629-y.


Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization.

Park B, Sardar Pasha S, Sishtla K, Hartman G, Qi X, Boulton M Int J Mol Sci. 2022; 23(24).

PMID: 36555236 PMC: 9779010. DOI: 10.3390/ijms232415595.


Characterization of the role of autophagy in retinal ganglion cell survival over time using a rat model of chronic ocular hypertension.

Lee S, Shim K, Kim C, Park T Sci Rep. 2021; 11(1):5767.

PMID: 33707562 PMC: 7952572. DOI: 10.1038/s41598-021-85181-x.


Adeno-associated virus (AAV)-based gene therapy for glioblastoma.

Xu X, Chen W, Zhu W, Chen J, Ma B, Ding J Cancer Cell Int. 2021; 21(1):76.

PMID: 33499886 PMC: 7836184. DOI: 10.1186/s12935-021-01776-4.


References
1.
Petrs-Silva H, Dinculescu A, Li Q, Min S, Chiodo V, Pang J . High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther. 2008; 17(3):463-71. PMC: 2835095. DOI: 10.1038/mt.2008.269. View

2.
Dominguez 2nd J, Hu P, Caballero S, Moldovan L, Verma A, Oudit G . Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice. Am J Pathol. 2016; 186(6):1688-700. PMC: 4901140. DOI: 10.1016/j.ajpath.2016.01.023. View

3.
Dalkara D, Kolstad K, Caporale N, Visel M, Klimczak R, Schaffer D . Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 2009; 17(12):2096-102. PMC: 2814392. DOI: 10.1038/mt.2009.181. View

4.
Benjamin L, Golijanin D, Itin A, Pode D, Keshet E . Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 1999; 103(2):159-65. PMC: 407882. DOI: 10.1172/JCI5028. View

5.
Askou A, Pournaras J, Pihlmann M, Svalgaard J, Arsenijevic Y, Kostic C . Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA. J Gene Med. 2012; 14(11):632-41. DOI: 10.1002/jgm.2678. View